Cash flow Ecolab Inc.

Equities

ECL

US2788651006

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:03 2026-02-06 pm EST			5-day change	1st Jan Change
290.33 ^USD	+1.09%		+2.96%	+10.59%

Feb. 06	Diary - U.S. earnings week ahead	RE
Jan. 26	Earnings calendar for January 26 to 30, 2026: Microsoft, Apple, LVMH and ASML ahead

aa247d484edc7fb4303de06cb691e7e._uNOy2gxIg5cEQ4eX77M_lhPBWzZYsM22afvNhL-na0.h5MkhR96bTsZRUItEIetoTd8bD63UaB8n-maB1i5sOe12x-9KXJuZTFWVw

Published financial data: ECOLAB INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	11.79B	12.73B	14.19B	15.32B	15.74B
Total Revenues	11.79B	12.73B	14.19B	15.32B	15.74B
Cost of Goods Sold, Total	6.86B	7.52B	8.76B	9.13B	8.89B
Gross Profit	4.93B	5.21B	5.43B	6.19B	6.85B
Selling General & Admin Expenses, Total	3.25B	3.34B	3.58B	4B	4.18B
Other Operating Expenses, Total	3.25B	3.34B	3.58B	4B	4.18B
Operating Income	1.68B	1.87B	1.85B	2.18B	2.67B
Interest Expense, Total	-221M	-198M	-252M	-349M	-340M
Interest And Investment Income	14.6M	12.3M	8.5M	52.2M	57.8M
Net Interest Expenses	-206M	-185M	-244M	-297M	-282M
Other Non Operating Income (Expenses)	-4.3M	-1.6M	-1M	2.7M	-
EBT, Excl. Unusual Items	1.47B	1.68B	1.6B	1.89B	2.39B
Restructuring Charges	-79.1M	-36.6M	-107M	-85.7M	-125M
Merger & Related Restructuring Charges	-13.1M	-34.9M	-39.5M	-16.1M	-12.6M
Asset Writedown	-	-	-	-	-
Other Unusual Items	-220M	-195M	-114M	-32.1M	322M
EBT, Incl. Unusual Items	1.16B	1.41B	1.34B	1.76B	2.57B
Income Tax Expense	177M	270M	234M	362M	439M
Earnings From Continuing Operations	985M	1.14B	1.11B	1.39B	2.13B
Earnings Of Discontinued Operations	-2.17B	-	-	-	-
Net Income to Company	-1.19B	1.14B	1.11B	1.39B	2.13B
Minority Interest	-17.4M	-14.1M	-17.2M	-20.7M	-19.5M
Net Income - (IS)	-1.21B	1.13B	1.09B	1.37B	2.11B
Net Income to Common Incl Extra Items	-1.21B	1.13B	1.09B	1.37B	2.11B
Net Income to Common Excl. Extra Items	967M	1.13B	1.09B	1.37B	2.11B
Per Share Items
Net EPS - Basic	-4.2	3.95	3.83	4.82	7.43
Basic EPS - Continuing Operations	3.37	3.95	3.83	4.82	7.43
Basic Weighted Average Shares Outstanding	287M	286M	285M	285M	284M
Net EPS - Diluted	-4.15	3.91	3.81	4.79	7.37
Diluted EPS - Continuing Operations	3.33	3.91	3.81	4.79	7.37
Diluted Weighted Average Shares Outstanding	290M	289M	287M	286M	287M
Normalized Basic EPS	3.15	3.62	3.46	4.07	5.18
Normalized Diluted EPS	3.11	3.59	3.44	4.05	5.14
Dividend Per Share	1.89	1.95	2.06	2.16	2.36
Payout Ratio	-46.54	50.13	55.22	44.98	31.45
Supplemental Items
EBITDA	2.5B	2.71B	2.79B	3.11B	3.61B
EBITA	1.9B	2.11B	2.17B	2.49B	2.97B
EBIT	1.68B	1.87B	1.85B	2.18B	2.67B
EBITDAR	2.68B	2.89B	2.98B	3.32B	3.82B
Total Revenues (As Reported)	11.79B	12.73B	14.19B	15.32B	15.74B
Effective Tax Rate - (Ratio)	15.21	19.11	17.46	20.65	17.09
Current Domestic Taxes	-43.9M	30.9M	146M	138M	301M
Current Foreign Taxes	260M	240M	231M	280M	323M
Total Current Taxes	216M	271M	377M	418M	624M
Deferred Domestic Taxes	12M	3.6M	-78.9M	-40.1M	-143M
Deferred Foreign Taxes	-51.3M	-4.5M	-63.7M	-15M	-41.5M
Total Deferred Taxes	-39.3M	-900K	-143M	-55.1M	-185M
Normalized Net Income	903M	1.04B	986M	1.16B	1.47B
Non-Cash Pension Expense	-49M	-37.1M	-26.9M	-62.2M	-53.1M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	185M	186M	190M	192M	207M
Net Rental Expense, Total	184M	179M	197M	215M	218M
Imputed Operating Lease Interest Expense	46.64M	34.85M	43.68M	67.7M	69.75M
Imputed Operating Lease Depreciation	137M	145M	153M	148M	148M
Stock-Based Comp., Other (Total)	82.1M	89.5M	87.8M	95.1M	135M
Total Stock-Based Compensation	82.1M	89.5M	87.8M	95.1M	135M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.26B	360M	599M	920M	1.26B
Total Cash And Short Term Investments	1.26B	360M	599M	920M	1.26B
Accounts Receivable, Total	2.27B	2.48B	2.7B	2.83B	2.86B
Other Receivables	169M	151M	184M	187M	163M
Total Receivables	2.44B	2.63B	2.88B	3.02B	3.03B
Inventory	1.29B	1.49B	1.79B	1.5B	1.46B
Prepaid Expenses	99.1M	121M	124M	144M	151M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	30.5M	84.5M	96.7M	62.4M	124M
Total Current Assets	5.12B	4.69B	5.49B	5.64B	6.03B
Gross Property Plant And Equipment	7.21B	7.58B	7.7B	8.21B	8.91B
Accumulated Depreciation	-3.66B	-3.89B	-3.96B	-4.18B	-4.44B
Net Property Plant And Equipment	3.55B	3.69B	3.74B	4.03B	4.48B
Goodwill	6.01B	8.06B	8.01B	8.15B	7.91B
Other Intangibles, Total	2.98B	4.22B	3.68B	3.49B	3.31B
Deferred Tax Assets Long-Term	163M	121M	108M	119M	156M
Other Long-Term Assets, Total	313M	425M	427M	413M	515M
Total Assets	18.13B	21.21B	21.46B	21.85B	22.39B
Liabilities
Accounts Payable, Total	1.16B	1.38B	1.73B	1.57B	1.81B
Accrued Expenses, Total	977M	1.05B	1.07B	1.32B	1.41B
Short-term Borrowings	15.5M	408M	3.7M	1.8M	3.6M
Current Portion of Long-Term Debt	1.8M	2.5M	501M	629M	612M
Current Portion of Leases	126M	115M	108M	126M	142M
Current Income Taxes Payable	96.1M	104M	198M	159M	127M
Unearned Revenue Current, Total	80.4M	91.7M	116M	111M	102M
Other Current Liabilities	475M	394M	482M	437M	582M
Total Current Liabilities	2.93B	3.55B	4.21B	4.35B	4.79B
Long-Term Debt	6.66B	8.34B	8.06B	7.54B	6.93B
Long-Term Leases	308M	291M	351M	439M	598M
Pension & Other Post Retirement Benefits	1.23B	894M	670M	652M	635M
Deferred Tax Liability Non Current	484M	622M	506M	418M	280M
Other Non Current Liabilities	312M	254M	406M	382M	366M
Total Liabilities	11.92B	13.95B	14.21B	13.77B	13.6B
Common Stock, Total	363M	364M	365M	366M	368M
Additional Paid In Capital	6.24B	6.46B	6.58B	6.77B	7.16B
Retained Earnings	8.24B	8.81B	9.32B	10.08B	11.52B
Treasury Stock	-6.68B	-6.78B	-7.3B	-7.31B	-8.31B
Comprehensive Income and Other	-1.99B	-1.63B	-1.73B	-1.85B	-1.98B
Total Common Equity	6.17B	7.22B	7.24B	8.04B	8.76B
Minority Interest	35M	28.9M	22.5M	27.5M	31.9M
Total Equity	6.2B	7.25B	7.26B	8.07B	8.79B
Total Liabilities And Equity	18.13B	21.21B	21.46B	21.85B	22.39B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	286M	287M	284M	286M	283M
ECS Total Common Shares Outstanding	286M	287M	284M	285M	283M
Book Value / Share	21.58	25.18	25.43	28.18	30.91
Tangible Book Value	-2.82B	-5.06B	-4.46B	-3.6B	-2.46B
Tangible Book Value Per Share	-9.86	-17.65	-15.67	-12.6	-8.68
Total Debt	7.11B	9.16B	9.03B	8.73B	8.28B
Net Debt	5.85B	8.8B	8.43B	7.81B	7.03B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.04B	646M	447M	443M	407M
Debt Equivalent Oper. Leases	1.47B	1.44B	1.58B	1.72B	1.74B
Minority Interest, Total (Incl. Fin. Div)	35M	28.9M	22.5M	27.5M	31.9M
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-15.6M	-115M	-179M	-119M	-105M
Inventories - Raw Materials, Total	511M	596M	849M	705M	607M
Inventories - Finished Goods, Total	790M	1.01B	1.12B	911M	962M
Land - (BS)	160M	159M	161M	156M	144M
Buildings, Total	1.06B	1.13B	1.13B	1.17B	1.15B
Machinery, Total	4.52B	4.68B	4.6B	4.87B	5.17B
Full Time Employees	44K	47K	47K	48K	48K
Accumulated Allowance for Doubtful Accounts (Supple)	84.3M	71.5M	131M	149M	122M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-1.21B	1.13B	1.09B	1.37B	2.11B
Depreciation & Amortization - CF	594M	604M	618M	617M	635M
Amortization of Goodwill and Intangible Assets - (CF)	218M	239M	320M	307M	300M
Depreciation & Amortization, Total	813M	843M	939M	924M	935M
(Gain) Loss From Sale Of Asset	-	-	-	-	-382M
Asset Writedown & Restructuring Costs	7.8M	-41.7M	66.2M	-32.6M	23.7M
Stock-Based Compensation (CF)	82.1M	89.5M	87.8M	95.1M	135M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	118M	-	-	-	-
Other Operating Activities, Total	2.25B	40.5M	-119M	-109M	-187M
Change In Accounts Receivable	156M	-178M	-320M	-84.3M	-147M
Change In Inventories	-180M	-73M	-403M	320M	-116M
Change In Accounts Payable	55.9M	200M	395M	-232M	300M
Change in Other Net Operating Assets	-241M	51.4M	51.1M	159M	138M
Cash from Operations	1.86B	2.06B	1.79B	2.41B	2.81B
Capital Expenditure	-489M	-643M	-713M	-775M	-994M
Sale of Property, Plant, and Equipment	5.3M	12.2M	2.2M	9.9M	11.3M
Cash Acquisitions	-487M	-3.92B	-7.2M	-180M	-313M
Divestitures	116M	-	-	-	890M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Other Investing Activities, Total	440M	-25.2M	1M	-45.2M	-27.4M
Cash from Investing	-414M	-4.58B	-717M	-990M	-434M
Short Term Debt Issued, Total	-	394M	-	-	1.9M
Long-Term Debt Issued, Total	1.86B	2.78B	494M	-	-
Total Debt Issued	1.86B	3.17B	494M	-	1.9M
Short Term Debt Repaid, Total	-65.5M	-	-404M	-1.9M	-
Long-Term Debt Repaid, Total	-1.65B	-1.05B	-	-500M	-630M
Total Debt Repaid	-1.71B	-1.05B	-404M	-502M	-630M
Issuance of Common Stock	242M	144M	29.1M	96.8M	259M
Repurchase of Common Stock	-146M	-107M	-518M	-13.7M	-986M
Common Dividends Paid	-561M	-566M	-603M	-617M	-664M
Common & Preferred Stock Dividends Paid	-561M	-566M	-603M	-617M	-664M
Other Financing Activities, Total	-19.6M	11.4M	165M	-18.6M	-4.2M
Cash from Financing	-342M	1.6B	-837M	-1.05B	-2.02B
Foreign Exchange Rate Adjustments	-30.1M	14.3M	4.4M	-45.7M	-18.7M
Net Change in Cash	1.07B	-900M	239M	321M	337M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	367M	276M	309M	469M	647M
Levered Free Cash Flow	1.83B	1.1B	1.31B	1.55B	1.93B
Unlevered Free Cash Flow	1.97B	1.22B	1.47B	1.77B	2.15B
Change In Net Working Capital	-514M	232M	-1.5M	-163M	-401M
Net Debt Issued / Repaid	143M	2.12B	89.7M	-502M	-628M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.4	5.94	5.42	6.3	7.55
Return on Total Capital	7.29	7.85	7.07	8.25	9.85
Return On Equity %	13.19	17.01	15.28	18.17	25.29
Return on Common Equity	13.03	16.88	15.1	17.96	25.14
Margin Analysis
Gross Profit Margin %	41.84	40.93	38.25	40.39	43.5
SG&A Margin	27.55	26.26	25.22	26.14	26.53
EBITDA Margin %	21.18	21.29	19.65	20.28	22.9
EBITA Margin %	16.14	16.54	15.29	16.26	18.87
EBIT Margin %	14.28	14.67	13.03	14.25	16.96
Income From Continuing Operations Margin %	8.35	8.98	7.82	9.09	13.54
Net Income Margin %	-10.22	8.87	7.69	8.96	13.42
Net Avail. For Common Margin %	8.21	8.87	7.69	8.96	13.42
Normalized Net Income Margin	7.66	8.14	6.95	7.57	9.36
Levered Free Cash Flow Margin	15.55	8.65	9.26	10.14	12.28
Unlevered Free Cash Flow Margin	16.73	9.62	10.37	11.57	13.63
Asset Turnover
Asset Turnover	0.6	0.65	0.66	0.71	0.71
Fixed Assets Turnover	3.26	3.52	3.82	3.94	3.7
Receivables Turnover (Average Receivables)	5.06	5.36	5.48	5.54	5.52
Inventory Turnover (Average Inventory)	5.79	5.42	5.33	5.55	6.01
Short Term Liquidity
Current Ratio	1.75	1.32	1.3	1.3	1.26
Quick Ratio	1.26	0.84	0.83	0.91	0.89
Operating Cash Flow to Current Liabilities	0.63	0.58	0.42	0.55	0.59
Days Sales Outstanding (Average Receivables)	72.26	68.11	66.59	65.9	66.26
Days Outstanding Inventory (Average Inventory)	63.16	67.38	68.42	65.75	60.94
Average Days Payable Outstanding	57.95	60.09	62.68	68.04	69.72
Cash Conversion Cycle (Average Days)	77.48	75.4	72.33	63.61	57.48
Long Term Solvency
Total Debt/Equity	114.69	126.23	124.36	108.19	94.24
Total Debt / Total Capital	53.42	55.8	55.43	51.97	48.52
LT Debt/Equity	112.39	118.98	115.91	98.82	85.61
Long-Term Debt / Total Capital	52.35	52.59	51.66	47.47	44.08
Total Liabilities / Total Assets	65.79	65.8	66.18	63.05	60.74
EBIT / Interest Expense	7.62	9.46	7.33	6.26	7.85
EBITDA / Interest Expense	12.13	14.63	11.84	9.52	11.24
(EBITDA - Capex) / Interest Expense	9.92	11.38	9.01	7.3	8.31
Total Debt / EBITDA	2.65	3.17	3.02	2.63	2.17
Net Debt / EBITDA	2.18	3.04	2.82	2.35	1.84
Total Debt / (EBITDA - Capex)	3.25	4.07	3.97	3.43	2.93
Net Debt / (EBITDA - Capex)	2.67	3.91	3.71	3.07	2.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.14	8	11.42	7.98	2.75
Gross Profit, 1 Yr. Growth %	-11.2	5.65	4.14	14.02	10.65
EBITDA, 1 Yr. Growth %	-12.79	8.57	2.83	11.49	15.94
EBITA, 1 Yr. Growth %	-17.06	10.72	2.98	14.86	19.16
EBIT, 1 Yr. Growth %	-19.33	10.91	-1.01	18.15	22.14
Earnings From Cont. Operations, 1 Yr. Growth %	-31.75	16.17	-3.07	25.62	53.04
Net Income, 1 Yr. Growth %	-177.3	-193.76	-3.38	25.7	53.93
Normalized Net Income, 1 Yr. Growth %	-22.79	14.73	-4.92	17.72	26.94
Diluted EPS Before Extra, 1 Yr. Growth %	-31.62	17.42	-2.56	25.72	53.86
Accounts Receivable, 1 Yr. Growth %	-4.54	9	8.86	5.04	1.09
Inventory, 1 Yr. Growth %	18.82	16.08	20.18	-16.49	-2.16
Net Property, Plant and Equip., 1 Yr. Growth %	-3.96	3.85	1.53	7.66	11.11
Total Assets, 1 Yr. Growth %	-13.14	16.99	1.22	1.78	2.48
Tangible Book Value, 1 Yr. Growth %	-1.59K	79.73	-11.98	-19.3	-31.64
Common Equity, 1 Yr. Growth %	-29	17.15	0.16	11.17	8.86
Cash From Operations, 1 Yr. Growth %	-23.15	10.84	-13.26	34.86	16.67
Capital Expenditures, 1 Yr. Growth %	-33.13	31.49	10.86	8.7	28.36
Levered Free Cash Flow, 1 Yr. Growth %	37.03	-39.95	19.24	18.37	24.27
Unlevered Free Cash Flow, 1 Yr. Growth %	33.95	-37.89	20.09	20.52	20.99
Dividend Per Share, 1 Yr. Growth %	2.16	3.17	5.64	4.85	9.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.78	0.68	9.7	9.69	5.33
Gross Profit, 2 Yr. CAGR %	-3.99	-3.14	4.89	8.97	12.33
EBITDA, 2 Yr. CAGR %	-3.02	-2.7	5.66	7.09	13.75
EBITA, 2 Yr. CAGR %	-5.24	-4.18	6.78	8.77	17.05
EBIT, 2 Yr. CAGR %	-6.45	-5.42	4.78	8.17	20.2
Earnings From Cont. Operations, 2 Yr. CAGR %	-11.8	-10.96	6.11	10.35	38.66
Net Income, 2 Yr. CAGR %	-8.17	-14.86	-4.82	10.21	39.1
Normalized Net Income, 2 Yr. CAGR %	-7.24	-5.88	4.44	5.8	22.24
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.69	-10.4	6.96	10.68	39.08
Accounts Receivable, 2 Yr. CAGR %	-7.59	2	8.93	6.94	3.05
Inventory, 2 Yr. CAGR %	-8.84	17.44	18.11	0.18	-9.61
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.82	-0.13	2.68	4.55	9.37
Total Assets, 2 Yr. CAGR %	-4.98	0.8	8.82	1.5	2.13
Tangible Book Value, 2 Yr. CAGR %	-0.96	418.03	25.78	-15.72	-25.73
Common Equity, 2 Yr. CAGR %	-12.22	-8.8	8.33	5.53	10.01
Cash From Operations, 2 Yr. CAGR %	-9.63	-7.71	-1.95	8.15	25.44
Capital Expenditures, 2 Yr. CAGR %	-20.76	-6.23	20.73	9.77	18.12
Levered Free Cash Flow, 2 Yr. CAGR %	39.2	-9.29	-15.38	18.83	21.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	34.29	-8.8	-13.64	20.33	20.81
Dividend Per Share, 2 Yr. CAGR %	5.75	2.67	4.4	5.25	7.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-5.19	1.37	4.14	9.12	7.33
Gross Profit, 3 Yr. CAGR %	-5.34	-0.88	-0.77	7.85	9.53
EBITDA, 3 Yr. CAGR %	-5.42	0.7	-0.89	7.56	9.99
EBITA, 3 Yr. CAGR %	-7	-0.19	-1.85	9.39	12.17
EBIT, 3 Yr. CAGR %	-6.46	-0.99	-3.97	9.04	12.68
Earnings From Cont. Operations, 3 Yr. CAGR %	-13.44	-3.32	-8.4	12.25	23.06
Net Income, 3 Yr. CAGR %	-7.13	-7.53	-11.2	4.43	23.19
Normalized Net Income, 3 Yr. CAGR %	-7.09	-0.43	-5.56	8.69	12.42
Diluted EPS Before Extra, 3 Yr. CAGR %	-13.36	-2.89	-7.86	12.88	23.53
Accounts Receivable, 3 Yr. CAGR %	-4.02	-2.36	4.24	7.62	4.95
Inventory, 3 Yr. CAGR %	-3.86	-1.19	18.35	5.22	-0.6
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.45	-1.33	0.42	4.31	6.69
Total Assets, 3 Yr. CAGR %	-3.17	1.85	0.94	6.42	1.82
Tangible Book Value, 3 Yr. CAGR %	-7.86	20.8	186.92	8.48	-21.4
Common Equity, 3 Yr. CAGR %	-6.66	-3.36	-5.9	9.27	6.63
Cash From Operations, 3 Yr. CAGR %	-3.83	-3.26	-9.6	9.04	10.92
Capital Expenditures, 3 Yr. CAGR %	-17.43	-6.18	-0.85	16.58	15.65
Levered Free Cash Flow, 3 Yr. CAGR %	13.78	5.18	-0.63	-5.38	20.66
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.02	3.85	-0.04	-3.51	20.58
Dividend Per Share, 3 Yr. CAGR %	7.53	4.89	3.65	4.55	6.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.74	-0.64	0.5	4.62	4.62
Gross Profit, 5 Yr. CAGR %	-5.08	-1.72	-1.38	2.95	4.27
EBITDA, 5 Yr. CAGR %	-3.06	-1.14	-1.13	3.2	4.72
EBITA, 5 Yr. CAGR %	-4.19	-1.82	-1.72	3.28	5.3
EBIT, 5 Yr. CAGR %	-3.92	-1.55	-2.12	2.56	5.04
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.65	-1.7	-6.09	1.93	8.12
Net Income, 5 Yr. CAGR %	3.76	-1.67	-6.21	-0.81	6.27
Normalized Net Income, 5 Yr. CAGR %	-4.17	-0.81	-2.64	2.02	4.71
Diluted EPS Before Extra, 5 Yr. CAGR %	0.06	-1.14	-5.74	2.32	8.64
Accounts Receivable, 5 Yr. CAGR %	-0.99	1.15	0.97	1.26	3.76
Inventory, 5 Yr. CAGR %	-1.53	2.49	4.39	-0.64	6.25
Net Property, Plant and Equip., 5 Yr. CAGR %	1.91	1.84	0.19	0.98	3.91
Total Assets, 5 Yr. CAGR %	-0.56	2.96	1.46	1.71	1.41
Tangible Book Value, 5 Yr. CAGR %	-5.25	8.94	4.36	4.6	67.11
Common Equity, 5 Yr. CAGR %	-2.25	0.92	-0.93	0.1	0.17
Cash From Operations, 5 Yr. CAGR %	-1.44	1.23	-3.08	1.15	3.06
Capital Expenditures, 5 Yr. CAGR %	-8.7	-3.21	-3.88	-0.1	6.34
Levered Free Cash Flow, 5 Yr. CAGR %	5.04	-7.02	1.07	10.42	7.63
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.37	-7.03	0.95	10.13	7.82
Dividend Per Share, 5 Yr. CAGR %	7.12	6.55	6.27	5.03	4.99